- Coordinator
- Nantes Universite, France
- Runs
- 1 August 2026 to 31 July 2028
- Status
- Running
- EU funding
- €242k
- Total cost
- —
- Partners
- 2 organisations in 2 countries
- Type
- Marie Skłodowska-Curie Action
- Grant agreement
- 101198435
What the project is doing
In the project's own words, from its summary on CORDIS.
Nosocomial pneumonia is the second most common and most frequently fatal hospital-acquired infection worldwide. Previous understanding of lung health depicted a dichotomous view of microbial status (sterile vs. infected), leading to ""one-size-fits-all"" treatments that primarily target pathogens but neglect the complex host-microbiome interaction. The RESTORE hypothesis is that re-establishing the healthy respiratory microbiome core using a probiotic composed of lung-specific commensal bacteria and/or their derived metabolites can mitigate pneumonia severity by modulating pathogens and mucosal immunity.
My main objectives are: 1) define lung-specific bacterial consortium and their derived metabolites/peptides, whose elimination is associated with pneumonia severity
Topics
Who is involved
| Organisation | City | Country | Role |
|---|---|---|---|
| Nantes Universite | Nantes | France | Coordinator |
| Regents of the University of Michigan | Ann Arbor | United States | Associatedpartner |
Source: CORDIS, European Commission. Data of 5 Nov 2026, reused under the Commission's reuse policy. View on CORDIS · Grant DOI